Medrhythms

Portland, ME · Founded 2013 · Privately Held (backing)

Provider of neurologic music therapy intended to offer evidence-based neurologic interventions to measure and improve walking. Medrhythms is based in Portland, ME and was founded in 2013. Its last reported valuation was $85 million in Jan 2024. It has raised $61.8 million across 7 recorded rounds; the latest was a $3.3 million seed round in Feb 2026.

Last reported valuation
$85.0M
Oct 2026
Priced at
—
Total raised
$61.8M
Last round
Seed Round
Feb 2026

Medrhythms key facts

as of Oct 2026
  • Provider of neurologic music therapy intended to offer evidence-based neurologic interventions to measure and improve walking.
  • Medrhythms is valued at approximately $85.0M as of Oct 2026 (last reported valuation).
  • It has raised $61.8M across 7 recorded rounds; the latest was Seed Round ($3.3M) in Feb 2026.
  • Notable investors include Global Brain, Harvard Innovation Launch Lab, Morningside Group, Peterson Partners, Maine Venture Fund — 14 tracked in total.
  • Medrhythms has filed 7 Form Ds with the SEC since 2018, most recently Apr 2025 ($2.9M sold to 3 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$85.0M

Medrhythms's last reported valuation, Jan 2024. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Medrhythms with a free account
  • ·The complete investor list: 14 names
  • ·Watch Medrhythms: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Medrhythms funding rounds

7 rounds
Feb 2026Seed Round$3.3MSEC filing▮
Mar 2025Seed Round$2.9MSEC filing▮
Nov 2023Early Stage VC$19.8MSEC filing▮
Feb 2023Early Stage VC$5.8MSEC filing▮
Jul 2021Early Stage VC$20.9MSEC filing▮

Medrhythms valuation

Medrhythms's last reported valuation was $85 million in Jan 2024. No priced round, secondary trade or fund mark has surfaced since.

How much has Medrhythms raised?

Medrhythms has raised $61.8 million across 7 recorded rounds since 2018. The largest was a $5.8 million early-stage round in Feb 2023; the most recent was a $3.3 million seed round in Feb 2026.

Medrhythms has filed 7 Form Ds with the SEC since 2018, most recently in Apr 2025 ($2.9 million sold to 3 investors).

Medrhythms investors

14 investors are on record for Medrhythms, including Global Brain, Harvard Innovation Launch Lab, Morningside Group and Peterson Partners. By type, the record holds 3 venture capital firms and 2 private equity firms. The seed round in Feb 2026 drew 31 investors.

About Medrhythms

Provider of neurologic music therapy intended to offer evidence-based neurologic interventions to measure and improve walking. The company's clinical programs use sensors, artificial intelligence, and music to develop neurologic interventions and also provide direct stimulation to help in the mechanism of action in each relevant population, enabling patients to use music to directly stimulate the brain and improve functional outcomes.

Sector
Healthcare
HQ
Portland, ME, United States
Founded
2013
Employees
46
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.